PEP kicked off Q2 2026 earnings season today before the bell. Markets are watching closely. The S&P 500's opening direction hinges partly on the PepsiCo print. DAL reports tomorrow. BAC and JNJ follow next week. The big-cap earnings conveyor belt is now moving.
The $110 billion merger between PSKY and WBD has stalled again. Oregon regulators want 60 more days to review the deal. The DOJ has already approved it. But state-level scrutiny is adding drag. Options flow is reflecting deal risk. Bears are circling both names.
CHWY short interest hit 75.4% of free float — up 5.6 points in a week. CRWV climbed to 32.7% as AI skeptics build positions. WOLF remains the most extreme read at 116.7%. Some covering emerged at CAR, where Avis Budget's SI fell 3.2 points to 36.2%.
FSLR was the week's analyst winner. Its consensus target edged higher to $251.26. INTU took the biggest cut — target dropped to $484.73 amid AI competition fears in tax software. NFLX also saw a modest trim.
AZN fell after its CARDIO-TTRansform Phase III trial for Wainua failed to meet its primary endpoint. That's a setback for its cardiovascular pipeline. In London, the FCA charged a solicitor with insider trading related to the Seraphine sale — a reminder that regulatory enforcement is active on both sides of the Atlantic.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
